Major players in the hematology diagnostics devices and equipment market are Abbott Diagnostics, Beckman Coulter, Bio-Rad Laboratories, Drucker Diagnostics, and Horiba Ltd.
The global hematology diagnostic devices and equipment market is expected to grow from $2.79 billion in 2020 to $4.31 billion in 2021 at a compound annual growth rate (CAGR) of 54.5%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $5.78 billion in 2025 at a CAGR of 7.6%.
The hematology diagnostics devices and equipment market consists of sales of hematology diagnostics devices and related services.Hematology diagnostics instruments are used to diagnose diseases related to blood, vascular systems, bone marrow, auto immune disorders and hemostasis.
These devices include automated cell counters, red cell indices devices, micro sedimentation centrifuges, or blood volume measuring devices, occult blood tests, platelet aggregometers, erythrocyte sedimentation rate tests, red blood cell enzyme assay kits, glutathione reductase assays and hematology reagents.
The hematology diagnostic devices market has a potential market to grow rapidly but stringent regulation policies are restricting their growth.The FDA currently regulates class I, class II, and class III hematology devices.
This means that class I hemostasis devices are regulated to use these devices are exempt from the premarket notification requirements and they only be used for the general controls. Regulations for class II devices are exempt from the premarket notification requirements and they can be used for special controls. Class III is the most stringent category as it requires premarket approval (PMA).
Companies in the hematology diagnostic devices are increasingly investing on the automation technology.Automation technology advancements are driving the demand for hematology analyzers and this automation will reduce the errors caused due to the manual practices in the diagnostic centers.
Example top companies like Sysmex acquired CLIA waiver for newly automated hematology analyzer and by selling this product, Sysmex makes it possible for clinical facilities to perform hematology testing without any manual errors.
Hematology diagnostic devices are driven by the increase in the prevalence of blood disorders.Hematology diagnostic devices are widely used in order to identify the type of blood disorder.
Blood disorder is a condition which is impacting the count of the blood cells like red blood cells, white blood cells, platelets, etc.Blood disorder affecting millions of people each year across the world irrespective of age, race, and sex.
E.g. As per the World Health Organization, Hemoglobin disorder is affecting 75% of the total births globally and the prevalence of Anemia is 12.7% is men.
Product recall is one of the major problems that the companies are facing.Product recalls is the process of returning the faulty devices which can be due to the errors in the manufacturing of the device.
Because of the faulty devices tests conducted in the diagnostic centers may get affected.Example, Becton Dickinson (BD) and Company recalled Vacutainer EDTA Blood Collection Tubes because they are affecting the test due to the chemical interference of test tubes with the blood samples.
This recall was classified as Class I recall, the most serious type of recall, by the Food and Drug Administration (FDA). Such product recalls can negatively affect market growth.
CLIA regulations establish quality standards for laboratory testing performed on specimens from humans, such as blood, body fluid and tissue, for the purpose of diagnosis, prevention, or treatment of disease, or assessment of health.
Our reports have been used by over 10K customers, including:
Executive Summary Global Medical Imaging Market was valued at USD 39.94 Billion in the year 2020. Medical Imaging refers to use of different imaging modalities to get visual representations of interior of a body for diagnostic and therapeutic purposes. The medical imaging field has advanced at a great pace, with technological...
The North America testing and commissioning market exhibited moderate growth during 2015-2020. Testing and commissioning involve a set of processes, performed to establish if a product follows universal regulatory standards or not. The certified regulations are associated to the quality, performance, and technical safety...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Medical Imaging Software Market Report
The global medical imaging software market by revenue is expected to grow at a CAGR of over 7% during the period 2020–2026.
Advances in imaging systems and analysis software that help reduce exposure...
2021 US Tumor Marker Testing Market--Competitive Shares and Strategic SWOT Analysis, Volume and Sales Segmentation Forecasts for Major Cancer Diagnostic Tests--Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
This unique report provides information and analysis not...
387 pages •
By Global Industry Analysts
• Apr 2021
- Global Multimodal Imaging Market to Reach $3.1 Billion by 2027
- Amid the COVID-19 crisis, the global market for Multimodal Imaging estimated at US$2.3 Billion in the year 2020, is projected to reach a revised size of US$3.1 Billion by 2027, growing at a CAGR of 4.3% over the analysis period 2020-2027....
Global Diagnostic Imaging Market By Product Type ( Architecture (Open/Closed), By Field Strength (High and Very-High Field MRI Systems)) By Systems (Ultrasound Systems, Nuclear Imaging Systems, X-Ray Imaging Systems, CT Scanner, MRI System, Mammography System, Fluoroscopy), By Portability (Stationary, Portability), By Application (OB/Gyn,...
The Global Diagnostic Imaging Partnering Terms and Agreements 2014 to 2021 report provides comprehensive understanding and unprecedented access to the diagnostic imaging partnering agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of...
The global brachytherapy market exhibited moderate growth during 2015-2020. Brachytherapy, also known as internal radiation therapy, is a form of radiotherapy in which radiation is transported directly through a source implanted near or next to the cancerous tumor in the body. The source produces gamma rays that are...
What’s Ahead for the Diagnostic Imaging Industry?--Emerging Opportunities and Growth Strategies for Suppliers A worldwide strategic overview of the diagnostic imaging market, including:·Estimates of the market size and growth.·Sales forecasts by geographic region and modality.·Review...
Infrared Thermography (IRT) Market Report - Global Industry Data, Analysis and Growth Forecasts by Type, Application and Region, 2021-2028 Infrared Thermography (IRT) market overview – Infrared Thermography (IRT) market illustrates an attractive growth rate during the forecast period with the advancements...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.